Skip to content

On-Eye Evaluation of Contact Lens Axis Location

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02100410
Enrollment
50
Registered
2014-04-01
Start date
2013-04-30
Completion date
2013-04-30
Last updated
2014-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia, Refractive Error

Keywords

Contact Lens, Toric

Brief summary

The purpose of this study was to evaluate the axis location of toric contact lenses after 3 minutes of wear. During this 1-visit study, each participant wore 3 pairs of study lenses of various design iterations (2-87-1, 2-87-2, 2-87-3) for an exposure time of approximately 30 minutes each. Each pair consisted of lenses of the same design iteration, 1 lens with embossed mark \[TEST1 (T1), TEST3 (T3), TEST5 (T5)\], worn on the right eye, and 1 lens without embossed mark \[TEST2 (T2), TEST4 (T4), and TEST6 (T6)\] worn on the left eye.

Interventions

DEVICEDelefilcon A toric contact lens T1

Iteration 2-87-1 with embossed mark

DEVICEDelefilcon A toric contact lens T2

Iteration 2-87-1 without embossed mark

DEVICEDelefilcon A toric contact lens T3

Iteration 2-87-2 with embossed mark

DEVICEDelefilcon A toric contact lens T4

Iteration 2-87-2 without embossed mark

DEVICEDelefilcon A toric contact lens T5

Iteration 2-87-3 with embossed mark

DEVICEDelefilcon A toric contact lens T6

Iteration 2-87-3 without embossed mark

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sign written Informed Consent. * Best corrected distance visual acuity greater than or equal to 20/25 in each eye. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* History of any ocular surgery or ocular injury within 12 weeks of enrollment for this study. * Anterior segment disease, infection, inflammation, or abnormality that contraindicates contact lens wear. * History of herpetic keratitis. * Slit-lamp findings at baseline as specified in the protocol. * Any use of systemic or ocular medications for which contact lens wear could be contraindicated, including ocular medications that require instillation during contact lens wear. * Clinically significant dry eye not responding to treatment. * History of refractive surgery. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Lenses With Axis Orientation ≤ 10 Degrees From Ideal Location After 3 Minutes of WearDay 1Axis orientation (the rotational positioning of the lens on the eye) was indicated by an axis mark. The actual location of the axis mark was evaluated during slit lamp review and compared to the ideal location for the axis mark, with the difference measured in degrees (0 to +/- 180). The ideal location for the axis mark was iteration-specific (either 6 o'clock or 3 and 9 o'clock). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).

Secondary

MeasureTime frameDescription
Lens AwarenessDay 1Lens awareness was assessed by the participant on a 5-point scale (0=none and 4=severe) within the first 5 minutes of wear for each eye separately.
Handling on RemovalDay 1Handling on removal (after 30 minutes of wear) was assessed by the participant on a scale from 1 to 10 (1=poor and 10=excellent). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).

Participant flow

Recruitment details

Participants were recruited from 1 study center located in the US.

Pre-assignment details

Of the 50 enrolled, 1 participant was exited as a screen failure prior to randomization and exposure to the study product. This reporting group includes all randomized participants (49).

Participants by arm

ArmCount
Overall
All treatment sequences
49
Total49

Baseline characteristics

CharacteristicOverall
Age, Customized
18 - 68 Years
45.4 years
STANDARD_DEVIATION 13.6
Sex: Female, Male
Female
29 Participants
Sex: Female, Male
Male
20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 490 / 49
serious
Total, serious adverse events
0 / 490 / 49

Outcome results

Primary

Percentage of Lenses With Axis Orientation ≤ 10 Degrees From Ideal Location After 3 Minutes of Wear

Axis orientation (the rotational positioning of the lens on the eye) was indicated by an axis mark. The actual location of the axis mark was evaluated during slit lamp review and compared to the ideal location for the axis mark, with the difference measured in degrees (0 to +/- 180). The ideal location for the axis mark was iteration-specific (either 6 o'clock or 3 and 9 o'clock). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).

Time frame: Day 1

Population: This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.

ArmMeasureValue (NUMBER)
TEST1Percentage of Lenses With Axis Orientation ≤ 10 Degrees From Ideal Location After 3 Minutes of Wear24.5 percentage of lenses
TEST3Percentage of Lenses With Axis Orientation ≤ 10 Degrees From Ideal Location After 3 Minutes of Wear46.9 percentage of lenses
TEST5Percentage of Lenses With Axis Orientation ≤ 10 Degrees From Ideal Location After 3 Minutes of Wear36.7 percentage of lenses
Secondary

Handling on Removal

Handling on removal (after 30 minutes of wear) was assessed by the participant on a scale from 1 to 10 (1=poor and 10=excellent). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).

Time frame: Day 1

Population: This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.

ArmMeasureValue (MEAN)Dispersion
TEST1Handling on Removal8.0 units on a scaleStandard Deviation 2.4
TEST3Handling on Removal7.8 units on a scaleStandard Deviation 2.6
TEST5Handling on Removal8.9 units on a scaleStandard Deviation 1.8
Secondary

Lens Awareness

Lens awareness was assessed by the participant on a 5-point scale (0=none and 4=severe) within the first 5 minutes of wear for each eye separately.

Time frame: Day 1

Population: This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.

ArmMeasureValue (MEAN)Dispersion
TEST1Lens Awareness0.6 units on a scaleStandard Deviation 0.8
TEST3Lens Awareness0.2 units on a scaleStandard Deviation 0.5
TEST5Lens Awareness0.4 units on a scaleStandard Deviation 0.7
TEST4Lens Awareness0.2 units on a scaleStandard Deviation 0.4
TEST5Lens Awareness1.0 units on a scaleStandard Deviation 1.1
TEST6Lens Awareness0.6 units on a scaleStandard Deviation 0.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026